BDBM50219327 GW811168X::PYRAZOLOPYRIMIDINE 2

SMILES COc1cccc(c1)-n1ncc2c(N\N=C\c3ccc(cc3)S(C)(=O)=O)ncnc12

InChI Key InChIKey=WKJFLAJZSWRICW-FOKLQQMPSA-N

Data  2 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50219327   

TargetGlycogen synthase kinase-3(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50219327(GW811168X | PYRAZOLOPYRIMIDINE 2)
Affinity DataIC50:  2.5nMAssay Description:Inhibition of glycogen synthase kinase-3 (GSK3-beta)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))TBA
LigandPNGBDBM50219327(GW811168X | PYRAZOLOPYRIMIDINE 2)
Affinity DataIC50:  2.5nMAssay Description:Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation countingMore data for this Ligand-Target Pair
In DepthDetails Article
TargetGlycogen synthase kinase-3(Homo sapiens (Human))
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50219327(GW811168X | PYRAZOLOPYRIMIDINE 2)
Affinity DataEC50:  310nMAssay Description:Inhibition of glycogen synthesis in rat skeletal muscle L6 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed